Gen1E Lifesciences
VerifiedDeveloping immunomodulators for rare and inflammatory diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$68—102m (Dealroom.co estimates Dec 2022.)
Palo Alto California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $17.0m | Early VC | |
| Total Funding | 000k | ||
Related Content
Recent News about Gen1E Lifesciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.